A COST-UTILITY ANALYSIS OF DEFERIPRONE COMPARED TO DESFERRIOXAMINE AND DEFERASIROX FOR THE TREATMENT OF CHRONIC IRON OVERLOAD IN PEOPLE WITH THALASSAEMIA: AN ITALIAN ADAPTATION OF THE UK MODEL

被引：0
|
作者：
Meloni, A. [1 ]
Neri, M. G. [1 ]
Bentley, A. [2 ]
Hanif, A. [2 ]
Pepe, A. [1 ]
机构：
[1] Fdn G Monasterio CNR Reg Toscana, CMR Unit, Pisa, Italy
[2] Abacus Int, Bicester, Oxon, England
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P425
引用
收藏
页码：150 / 150
页数：1
相关论文
共 27 条
  • [21] COST-UTILITY ANALYSIS OF SINGLE DOSE GENE-REPLACEMENT THERAPY FOR SPINAL MUSCULAR ATROPHY TYPE 1 COMPARED TO CHRONIC NUSINERSEN TREATMENT
    Malone, D.
    Dean, R.
    Miller, B.
    Arjunji, R.
    Feltner, D. E.
    Sproule, D. M.
    Jensen, I. S.
    Maru, B.
    Dabbous, O.
    VALUE IN HEALTH, 2019, 22 : S42 - S43
  • [22] Direct Cost Analysis About The Three Chelators For The Treatment Of Thalassemia Patients With Chronic Iron Overload: An Italian Perspective From The MIOT Network
    Pepe, Alessia
    Meloni, Antonella
    Rossi, Giuseppe
    Carollo, Antonella
    Santamaria, Vincenzo
    Scaccetti, Augusto
    Roccamo, Gaetano
    Maggio, Aurelio
    Lombardi, Massimo
    BLOOD, 2013, 122 (21)
  • [23] DIRECT COST ANALYSIS ABOUT THE THREE CHELATORS FOR THE TREATMENT OF THALASSEMIA PATIENTS WITH CHRONIC IRON OVERLOAD: AN ITALIAN PERSPECTIVE FROM THE MIOT NETWORK
    Pepe, A.
    Meloni, A.
    Rossi, G.
    Cardinale, A.
    Pietrapertosa, A.
    Giugno, G. R.
    Preziosi, P.
    Renne, S.
    Salvatori, C.
    Filosa, A.
    HAEMATOLOGICA, 2014, 99 : 489 - 489
  • [24] COST-UTILITY ANALYSIS OF SINGLE DOSE GENE-REPLACEMENT THERAPY FOR SPINAL MUSCULAR ATROPHY TYPE 1 COMPARED TO CHRONIC NUSINERSEN TREATMENT IN JAPAN
    Dean, R.
    Miller, B.
    Arjunji, R.
    Awano, H.
    Igarashi, A.
    Tanaka, S.
    Feltner, D. E.
    Sproule, D. M.
    Jensen, I
    Dabbous, O.
    VALUE IN HEALTH, 2020, 23 : S239 - S239
  • [25] COST-UTILITY ANALYSIS OF ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITOR SACUBITRIL/VALSARTAN COMPARED WITH ACE INHIBITORS FOR THE TREATMENT OF CHRONIC HEART FAILURE IN THE UNITED STATES
    Harrington, R. L.
    Zueger, P. M.
    Kumar, V. M.
    Rigoni, G.
    Atwood, A. M.
    DiDomenico, R. J.
    Touchette, D. R.
    VALUE IN HEALTH, 2016, 19 (03) : A49 - A49
  • [26] A UK multi-centre trial-based cost-utility analysis of surgical stabilisation of the spine versus intensive rehabilitation for treatment of chronic low back pain patients
    Rivero-Arias, O
    Campbell, H
    Gray, A
    VALUE IN HEALTH, 2003, 6 (06) : 773 - 773
  • [27] A COST-UTILITY ANALYSIS ON THE USE OF TRASTUZUMAB plus ANASTROZOLE COMPARED TO LAPATINIB plus LETROZOLE, LETROZOLE MONOTHERAPY OR ANASTROZOLE MONOTHERAPY IN THE TREATMENT OF HER2+/HORMONE RECEPTOR POSITIVE (HR plus ) METASTATIC BREAST CANCER (MBC) FROM THE PERSPECTIVE OF THE UK NATIONAL HEALTH SERVICE (NHS)
    McNamara, S.
    Moore, L.
    Ray, J.
    VALUE IN HEALTH, 2010, 13 (07) : A269 - A269
123